In brief, what’s happening at Penn—whether it’s across campus or around the world.
A study led by Eric J. Brown, an associate professor of cancer biology in the Perelman School of Medicine, identifies a new approach to the molecular mechanism of cancer drugs could aid in better identifying the best treatments for patients for an array of cancers.
FULL STORY AT Penn Medicine News →
Alan Ruby, a Senior Fellow at Penn GSE and senior scholar with Penn AHEAD, reflects on helping launch Kazakhstan’s first research intensive English language university.
FULL STORY AT Graduate School of Education →
Wharton's Olivia Mitchell discusses her research on how to convince people to delay claiming Social Security benefits.
FULL STORY AT Knowledge at Wharton →
Trout is an assistant professor of women’s health in the Department of Family and Community Health, and the track lead of the Nurse-Midwifery Graduate Program.
FULL STORY AT Penn Nursing News →
Experts in nephrology and health policy call for more transparency about joint-venture ownership of dialysis clinics to better understand what impact these arrangements may have on patient referrals and clinical outcomes.
FULL STORY AT Penn Medicine News →
During Hurricane Florence last month, Penn Vet’s Sue McDonnell, founding head of the Equine Behavior Program at New Bolton Center, and Carlo Siracusa, clinical assistant professor of behavior medicine at Ryan Hospital, discuss how animals respond to weather emergencies and what owners, caretakers, and concerned citizens can do to keep them safe.
FULL STORY AT Penn Vet →
Wharton's John Paul MacDuffie and David Zaring discuss the Securities and Exchange Commission's settlement with Musk, which allows him to remain CEO of Tesla.
FULL STORY AT Knowledge at Wharton →
For the second time this season, senior goalkeeper Scott Forbes has been named Philadelphia Soccer Six Defensive Player of the Week, following a career performance in Penn's Ivy opener at Cornell.
FULL STORY AT Penn Athletics →
U.S. Food and Drug Administration Commissioner Scott Gottlieb was the keynote speaker at Penn’s “Cost of a Cure" conference on precision medicine, where he announced two new draft guidelines for clinical trial protocols.
FULL STORY AT Leonard Davis Institute →
The market dominance of American technology firms is giving rise to a call for antitrust intervention that is slowly but surely gaining momentum.
FULL STORY AT Wharton Public Policy Initiative →
